Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History PRPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics PRPH

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield 267.81 %
Consecutive Years 0
Forward Annual Dividend 1.00 USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 06.06.2018

ProPhase Labs Inc

PRPH
Current price
0.37 USD +0.0014 USD (+0.38%)
Last closed 0.37 USD
ISIN US74345W1080
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 17 854 408 USD
Yield for 12 month -88.37 %
1Y
3Y
5Y
10Y
15Y
PRPH
21.11.2021 - 28.11.2021

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tests obtained from other service providers; and LB-1 and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory related syndromes, diseases or symptoms, including dementia and Alzheimer's disease. In addition, the company provides a broad range of COVID-19 related clinical diagnostic and testing services, comprising PCR testing for COVID-19, and Influenza A and B, as well as rapid antigen testing for COVID-19. It offers its genome sequencing products to consumers online with plans to sell in food, drug, and mass retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York. Address: 711 Stewart Avenue, Garden City, NY, United States, 11530

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13.80 USD

P/E Ratio

Dividend Yield

Financials PRPH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures PRPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+6 770 000 USD

Last Year

+44 384 000 USD

Current Quarter

+1 431 000 USD

Last Quarter

-2 484 000 USD

Current Year

-150 000 USD

Last Year

+16 239 000 USD

Current Quarter

+526 000 USD

Last Quarter

+924 000 USD
EBITDA -28 597 000 USD
Operating Margin TTM -255.98 %
Price to Earnings
Return On Assets TTM -30.92 %
PEG Ratio
Return On Equity TTM -162.30 %
Wall Street Target Price 13.80 USD
Revenue TTM 5 845 000 USD
Book Value 0.36 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -39.30 %
Dividend Yield
Gross Profit TTM 436 000 USD
Earnings per share -2.23 USD
Diluted Eps TTM -2.23 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -95.20 %
Profit Margin

Stock Valuation PRPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 10.09
Enterprise Value Revenue 5.40
Price Sales TTM 3.05
Enterprise Value EBITDA 2.45
Price Book MRQ 1.17

Technical Indicators PRPH

For 52 Weeks

0.22 USD 3.45 USD
50 Day MA 0.35 USD
Shares Short Prior Month 156 140
200 Day MA 0.80 USD
Short Ratio 0.090
Shares Short 1 100 402
Short Percent 0.42 %